A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C
Clinical trial NCT01482390 · COMPLETED
Trial details
- NCT number
- NCT01482390
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-30
- Primary completion
- 2014-01-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.